Literature DB >> 26719433

Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?

Juergen Prattes1, Reinhard B Raggam2, Kim Vanstraelen3, Jasmin Rabensteiner4, Christoph Hoegenauer5, Robert Krause1, Florian Prüller4, Albert Wölfler6, Isabel Spriet3, Martin Hoenigl7.   

Abstract

Blood citrulline and intestinal fatty acid binding protein were determined as biomarkers for intestinal mucositis. Biomarker levels were correlated with corresponding serum 1,3-beta-D-glucan levels in 56 samples obtained from 33 cases with underlying hematological malignancies receiving induction chemotherapy. No correlation between biomarkers of intestinal mucositis and BDG levels was observed. (This study has been registered at ClinicalTrials.gov under registration no. NCT01576653.).
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26719433      PMCID： PMC4767967          DOI： 10.1128/JCM.02972-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Intracellular fatty-acid-binding proteins. Characteristics and function.

Authors:  R J Paulussen; J H Veerkamp
Journal:  Subcell Biochem       Date:  1990

2.  Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.

Authors:  Jürgen Prattes; Martin Hoenigl; Jasmin Rabensteiner; Reinhard B Raggam; Florian Prueller; Ines Zollner-Schwetz; Thomas Valentin; Katharina Hönigl; Sonja Fruhwald; Robert Krause
Journal:  Mycoses       Date:  2014-07-15       Impact factor: 4.377

3.  Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia.

Authors:  J M Lieberman; J Sacchettini; C Marks; W H Marks
Journal:  Surgery       Date:  1997-03       Impact factor: 3.982

4.  A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients.

Authors:  J P Donnelly; P Muus; A Schattenberg; T De Witte; A Horrevorts; B E DePauw
Journal:  Bone Marrow Transplant       Date:  1992-06       Impact factor: 5.483

5.  Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract.

Authors:  M-E Bougnoux; D Diogo; N François; B Sendid; S Veirmeire; J F Colombel; C Bouchier; H Van Kruiningen; C d'Enfert; D Poulain
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 6.  Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.

Authors:  Justyna A Barzał; Cezary Szczylik; Piotr Rzepecki; Małgorzata Jaworska; Elżbieta Anuszewska
Journal:  Acta Biochim Pol       Date:  2014-12-04       Impact factor: 2.149

7.  Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease.

Authors:  Pascal Crenn; Kouroche Vahedi; Anne Lavergne-Slove; Luc Cynober; Claude Matuchansky; Bernard Messing
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

8.  Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.

Authors:  Ludy C H W Lutgens; Nicolaas Deutz; Marlies Granzier-Peeters; Regina Beets-Tan; Dirk De Ruysscher; John Gueulette; Jack Cleutjens; Martijn Berger; Bradly Wouters; Maarten von Meyenfeldt; Philippe Lambin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

9.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

10.  Candida colonization and subsequent infections in critically ill surgical patients.

Authors:  D Pittet; M Monod; P M Suter; E Frenk; R Auckenthaler
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969
View more
  7 in total

Review 1.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

2.  Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

3.  (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.

Authors:  Martin Hoenigl; Michelli Faria de Oliveira; Josué Pérez-Santiago; Yonglong Zhang; Sheldon Morris; Allen J McCutchan; Malcolm Finkelman; Thomas D Marcotte; Ronald J Ellis; Sara Gianella
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 4.  Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.

Authors:  Sven Heldt; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2017-04-29

5.  Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery.

Authors:  Alexander Szyszkowitz; Christoph Zurl; Anna Herzeg; Anton Berger; Geza Gemes; Martin Mitteregger; Florian Prüller; Juergen Prattes; Ines Zollner-Schwetz; Thomas Valentin; Martin Hoenigl; Robert Krause
Journal:  Open Forum Infect Dis       Date:  2018-11-08       Impact factor: 3.835

6.  Bacterial translocation in acute lymphocytic leukemia.

Authors:  Yajing Song; Peter Gyarmati
Journal:  PLoS One       Date:  2019-04-01       Impact factor: 3.240

7.  (1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?

Authors:  Martin Hoenigl; Josué Pérez-Santiago; Masato Nakazawa; Michelli Faria de Oliveira; Yonglong Zhang; Malcolm A Finkelman; Scott Letendre; Davey Smith; Sara Gianella
Journal:  Front Immunol       Date:  2016-10-03       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.